Results 131 to 140 of about 11,480 (212)

PLATELET ANTIAGGREGANTS: MECHANISMS OF ACTION AND USE ASOCIED RISKS

Vitae, 2009
Cardiovascular diseases are the main cause of death in the world. Next to efforts to reduce the cardiovascular risk factors, several drugs are resorted to decrease morbimortality associated to these diseases: antihypertensive, antidiabetic, hypolipemiant
Iván F. PALOMO G, Constanza I. TORRES U., Rodrigo E. MOORE-Carrasco., Marcelo A. ALARCÓN L., Patricio J. MARAGAÑO L.   +4 more
doaj  

Adverse Drug Effect Profiles of Gp2b/3a Inhibitors: A Comparative Review of the Last Two Decades. [PDF]

Cureus, 2023
Hasan N, Jauregui W, Zubair M, Pushparajan VK, Carson BJ, Attaluri DM, Dixon D, Jaisinghani A, Chuecos A, Ravichandran D.   +9 more
europepmc   +1 more source

Tirofiban-induced thrombocytopenia. [PDF]

Ann Med, 2023
Wang J, Zou D.
europepmc   +1 more source

abciximab

, 2001

openalex   +2 more sources

Abciximab (ReoPro) Dosing Strategy for the Management of Acute Intraprocedural Thromboembolic Complications during Pipeline Flow Diversion Treatment of Intracranial Aneurysms [PDF]

, 2018
Li-Mei Lin, Bowen Jiang, Jessica K Campos, Narlin Beaty, Matthew T. Bender, Rafael J. Tamargo, Judy Huang, Geoffrey P. Colby, Alexander L. Coon   +8 more
openalex   +1 more source

Abciximab-induced acute profound thrombocytopenia postpercutaneous coronary intervention [PDF]

, 2017
Todd Golden, Sehem Ghazala, Rita Wadeea, Shilpa Junna   +3 more
openalex   +1 more source

Acute Profound Thrombocytopenia Secondary to Local Abciximab Infusion [PDF]

, 2012
Matthew N. Peters, Christopher Press, John Moscona, Rashad H. Khazi Syed, Morgan J. Katz, Alison A Egan, Mohannad Bisharat, Vikram S. Nijjar, Asif Anwar   +8 more
openalex   +1 more source

Are tirofiban and abciximab identical in efficacy? [PDF]

, 2005
Fahim Haider Jafary
openalex   +1 more source

Bleeding Complications of Anticoagulation Therapy Used in the Treatment of Acute Coronary Syndromes-Review of the Literature. [PDF]

J Clin Med
Kosowski M, Kocjan M, Mazurkiewicz M, Gamrot-Wrzoł M, Ryl S, Nowakowski K, Kawecki J, Kukulski T, Kawecki D, Morawiec-Migas B.   +9 more
europepmc   +1 more source

Eptifibatide is associated with significant cost savings and similar clinical outcomes to abciximab when used during primary percutaneous coronary intervention for ST-elevation myocardial infarction: An observational cohort study of 3863 patients [PDF]

, 2017
Krishnaraj S. Rathod, Sotiris Antoniou, Parizad Avari, Nannan Ding, P Wright, C Knight, Arun K. Jain, Anthony Mathur, EJ Smith, Roshan Weerackody, Andrew Wragg, Daniel A. Jones   +11 more
openalex   +1 more source